Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 1
1950 1
1952 3
1955 2
1956 3
1957 2
1958 1
1959 1
1960 3
1961 3
1962 4
1963 5
1964 9
1965 4
1966 7
1967 12
1968 10
1969 13
1970 15
1971 21
1972 15
1973 21
1974 21
1975 19
1976 14
1977 18
1978 22
1979 10
1980 17
1981 16
1982 19
1983 15
1984 17
1985 28
1986 20
1987 18
1988 25
1989 23
1990 26
1991 24
1992 21
1993 42
1994 33
1995 43
1996 43
1997 23
1998 32
1999 29
2000 34
2001 32
2002 35
2003 32
2004 26
2005 46
2006 44
2007 41
2008 25
2009 35
2010 39
2011 32
2012 60
2013 61
2014 51
2015 39
2016 51
2017 35
2018 24
2019 25
2020 38
2021 36
2022 12
2023 19
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

1,571 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Vos JL, Elbers JBW, Krijgsman O, Traets JJH, Qiao X, van der Leun AM, Lubeck Y, Seignette IM, Smit LA, Willems SM, van den Brekel MWM, Dirven R, Baris Karakullukcu M, Karssemakers L, Klop WMC, Lohuis PJFM, Schreuder WH, Smeele LE, van der Velden LA, Bing Tan I, Onderwater S, Jasperse B, Vogel WV, Al-Mamgani A, Keijser A, van der Noort V, Broeks A, Hooijberg E, Peeper DS, Schumacher TN, Blank CU, de Boer JP, Haanen JBAG, Zuur CL. Vos JL, et al. Among authors: vogel wv. Nat Commun. 2021 Dec 22;12(1):7348. doi: 10.1038/s41467-021-26472-9. Nat Commun. 2021. PMID: 34937871 Free PMC article. Clinical Trial.
A mechanistic classification of clinical phenotypes in neuroblastoma.
Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M. Ackermann S, et al. Among authors: vogel w. Science. 2018 Dec 7;362(6419):1165-1170. doi: 10.1126/science.aat6768. Science. 2018. PMID: 30523111 Free PMC article.
The tubarial salivary glands: A potential new organ at risk for radiotherapy.
Valstar MH, de Bakker BS, Steenbakkers RJHM, de Jong KH, Smit LA, Klein Nulent TJW, van Es RJJ, Hofland I, de Keizer B, Jasperse B, Balm AJM, van der Schaaf A, Langendijk JA, Smeele LE, Vogel WV. Valstar MH, et al. Among authors: vogel wv. Radiother Oncol. 2021 Jan;154:292-298. doi: 10.1016/j.radonc.2020.09.034. Epub 2020 Sep 23. Radiother Oncol. 2021. PMID: 32976871 Free article.
Li-Fraumeni Syndrome.
Vogel WH. Vogel WH. J Adv Pract Oncol. 2017 Nov-Dec;8(7):742-746. Epub 2017 Nov 1. J Adv Pract Oncol. 2017. PMID: 30333936 Free PMC article. Review. No abstract available.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Beelen DW, Trenschel R, Stelljes M, Groth C, Masszi T, Reményi P, Wagner-Drouet EM, Hauptrock B, Dreger P, Luft T, Bethge W, Vogel W, Ciceri F, Peccatori J, Stölzel F, Schetelig J, Junghanß C, Grosse-Thie C, Michallet M, Labussiere-Wallet H, Schaefer-Eckart K, Dressler S, Grigoleit GU, Mielke S, Scheid C, Holtick U, Patriarca F, Medeot M, Rambaldi A, Micò MC, Niederwieser D, Franke GN, Hilgendorf I, Winkelmann NR, Russo D, Socié G, Peffault de Latour R, Holler E, Wolff D, Glass B, Casper J, Wulf G, Menzel H, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, Grass S, Iori AP, Finke J, Benedetti F, Pichlmeier U, Hemmelmann C, Tribanek M, Klein A, Mylius HA, Baumgart J, Dzierzak-Mietla M, Markiewicz M. Beelen DW, et al. Among authors: vogel w. Lancet Haematol. 2020 Jan;7(1):e28-e39. doi: 10.1016/S2352-3026(19)30157-7. Epub 2019 Oct 9. Lancet Haematol. 2020. PMID: 31606445 Clinical Trial.
Presenting With Confidence.
Vogel WH, Viale PH. Vogel WH, et al. J Adv Pract Oncol. 2018 Jul-Aug;9(5):545-548. Epub 2018 Jul 1. J Adv Pract Oncol. 2018. PMID: 31086691 Free PMC article. Review.
Detector-Agnostic Phase-Space Distributions.
Sperling J, Phillips DS, Bulmer JFF, Thekkadath GS, Eckstein A, Wolterink TAW, Lugani J, Nam SW, Lita A, Gerrits T, Vogel W, Agarwal GS, Silberhorn C, Walmsley IA. Sperling J, et al. Among authors: vogel w. Phys Rev Lett. 2020 Jan 10;124(1):013605. doi: 10.1103/PhysRevLett.124.013605. Phys Rev Lett. 2020. PMID: 31976720
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
Heitmann JS, Schlenk RF, Dörfel D, Kayser S, Döhner K, Heuser M, Thol F, Kapp-Schwoerer S, Labrenz J, Edelmann D, Märklin M, Vogel W, Bethge W, Walz JS, Große-Hovest L, Steiner M, Jung G, Salih HR. Heitmann JS, et al. Among authors: vogel w. J Hematol Oncol. 2023 Aug 17;16(1):96. doi: 10.1186/s13045-023-01490-w. J Hematol Oncol. 2023. PMID: 37587502 Free PMC article. Clinical Trial.
Liver tumors and loco-regional therapy.
Vogel W. Vogel W. Wien Med Wochenschr. 2013 Mar;163(5-6):107-8. doi: 10.1007/s10354-013-0188-2. Wien Med Wochenschr. 2013. PMID: 23456251 No abstract available.
1,571 results